Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

Erstveröffentlichung

2007

Authors

Kropff, Martin

Bisping, Guido

Schuck, Elke

Liebisch, Peter

Lang, Nicola

et al.

Wissenschaftlicher Artikel

Published in

British Journal of Haematology ; 138 (2007), 3. - S. 330-337. - ISSN 0007-1048. - eISSN 1365-2141

Link to publication

https://dx.doi.org/10.1111/j.1365-2141.2007.06656.x

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: myeloma | relapsed | chemotherapy | bortezomib | cyclophosphamide | PROTEASOME INHIBITOR PS-341 | CHEMOTHERAPEUTIC-AGENTS | MELPHALAN | TRIAL | SENSITIVITY | THALIDOMIDE | PREDNISONE | THERAPY | CANCER | CELLS
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record